Not applicableStudy completedNCT01505699What this trial is testingBiomarkers in Samples From Patients With B-Cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group 186
Testing effectiveness (Phase 2)Study completedNCT00002925What this trial is testingCombination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous LeukemiaWho this might be right forLeukemia National Cancer Institute (NCI) 410
Not applicableUnknownNCT06347562What this trial is testingOptical Genome Mapping for the Diagnosis of Neurodevelopmental DisordersWho this might be right forNeurodevelopmental Disorder (Diagnosis) IRCCS Eugenio Medea 58
Not applicableStudy completedNCT01490853What this trial is testingFollow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based TherapyWho this might be right forChronic Myeloid Leukemia Università degli Studi di Brescia 116
Not applicableStudy completedNCT00896129What this trial is testingMid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line TherapyWho this might be right forChronic Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 448
Not applicableUnknownNCT01004640What this trial is testingStudy of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical TrialWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 60
Large-scale testing (Phase 3)Ended earlyNCT01827930What this trial is testingPhase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular ResponseWho this might be right forLeukemia, Myeloid, Chronic-Phase Institut Bergonié 68
Not applicableActive Not RecruitingNCT04378855What this trial is testingPatient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).Who this might be right forMyeloproliferative Neoplasm Gruppo Italiano Malattie EMatologiche dell'Adulto 572
Large-scale testing (Phase 3)Ended earlyNCT00362466What this trial is testingDasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib TherapyWho this might be right forLeukemia Bristol-Myers Squibb 3
Not applicableStudy completedNCT01648556What this trial is testingResearch of Predictive Factors to Immune Thrombopenic PurpuraWho this might be right forPurpura Thrombopenic Centre Hospitalier Universitaire, Amiens 37
Not applicableStudy completedNCT00900042What this trial is testingSWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer SWOG Cancer Research Network 34
Not applicableStudy completedNCT00898183What this trial is testingS9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic MelanomaWho this might be right forMelanoma (Skin) SWOG Cancer Research Network 91
Testing effectiveness (Phase 2)Study completedNCT00065156What this trial is testingLenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic AbnormalityWho this might be right forMyelodysplastic Syndromes Celgene 148
Testing effectiveness (Phase 2)Study completedNCT01584531What this trial is testingEfficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic SyndromeWho this might be right forMyelodysplastic SyndromeMDSTrisomy 8 Traws Pharma, Inc. 82
Testing effectiveness (Phase 2)Study completedNCT00072579What this trial is testingSargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial TreatmentWho this might be right forLeukemia Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT01534260What this trial is testingPhase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive GenotypeWho this might be right forAcute Myeloid Leukemia Hamid Sayar 37
Early research (Phase 1)Study completedNCT01471067What this trial is testingCord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesWho this might be right forBlood And Marrow TransplantationLeukemiaLymphoma+2 more M.D. Anderson Cancer Center 33
Not applicableStudy completedNCT00390715What this trial is testingTreatment of Acute Myeloblastic Leukemia in Younger PatientsWho this might be right forAcute Myeloblastic Leukemia PETHEMA Foundation 600
Not applicableLooking for participantsNCT07680868What this trial is testingCaris Chromoseq Data CollectionWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic (MDS) / Myeloproliferative (MPN) DiseasesMyelodysplatic Syndromes+1 more Caris Science, Inc. 300
Post-approval studies (Phase 4)Study completedNCT01243489What this trial is testingCompliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND OptimisationWho this might be right forChronic Myelogenous Leukemia (CML) Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 104